Noroxymorphone Synthesis via Selective Oxidation and Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing noroxymorphone, a key starting material for semi-synthetic opiate derivatives, are inefficient and result in lower purity, leading to a need for improved synthesis processes.
Innovation Solution
Development of new processes and compounds for preparing normorphinan compounds, including specific reaction schemes and intermediates, which enhance yield and reduce side-products, utilizing various reactants and conditions such as acids, oxidizing agents, and proton acceptors to achieve higher purity noroxymorphone production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current multi-step processes are used to produce noroxymorphone, then production can be achieved, but the yield is low and purity is reduced due to inefficiencies and side-products
Solution Approach 1:
The patent employs parameter changes by utilizing specific reaction conditions including temperature control, solvent selection, and reagent ratios to optimize the synthesis process. The use of vinyl chloroformate at controlled temperatures and specific molar ratios demonstrates parameter optimization to improve both yield and purity while minimizing side-products
Solution Approach 2:
The patent uses intermediate compounds with specific protective groups (such as t-butyldimethylsilyl groups) that facilitate selective reactions. These intermediaries enable stepwise synthesis with higher precision, allowing the final product to achieve greater purity while maintaining efficient production through controlled transformation stages
2Productivity
If oxidation reactions are used to convert morphine derivatives, then noroxymorphone can be produced, but undesirable side-products are formed reducing overall efficiency
Solution Approach 1:
The patent applies local quality by using selective oxidation at specific positions of the morphine molecule through protected intermediate structures. The protective groups ensure that oxidation occurs only at desired locations (C-14 hydroxylation), preventing unwanted side reactions and minimizing harmful by-products while maintaining high synthesis efficiency
Solution Approach 2:
The patent converts potentially harmful oxidation side reactions into beneficial selective transformations by using controlled oxidation conditions with specific reagents. The oxidation process, when properly controlled, produces the desired 14-hydroxylated product while minimizing unwanted by-products, effectively turning a potentially harmful process into a beneficial one
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed processes result in more efficient production of noroxymorphone with higher yields and fewer undesirable side-products, addressing the inefficiencies of existing methods and improving the purity of the final product.
Implementation Method 1
3-O-t-butyldimethylsilylmorphine is oxidised by using manganese dioxide to yield the corresponding morphinone
Implementation Method 2
The morphinone is further oxidised to the 14-hydroxymorphinone
Implementation Method 3
After hydrogenation, the 7,8-dihydro-14-hydroxymorphinone
Data Source
AI summary
The invention generally provides processes and intermediate compounds useful for the production of normorphinans and derivatives of normorphinans.